Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 3
2019 2
2020 4
2021 5
2022 1
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study.
Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestøl K, Maddison J, Askautrud HA, Pradhan M, Nesheim JA, Albregtsen F, Farstad IN, Domingo E, Church DN, Nesbakken A, Shepherd NA, Tomlinson I, Kerr R, Novelli M, Kerr DJ, Danielsen HE. Skrede OJ, et al. Among authors: kleppe a. Lancet. 2020 Feb 1;395(10221):350-360. doi: 10.1016/S0140-6736(19)32998-8. Lancet. 2020. PMID: 32007170 Clinical Trial.
Clinical utility of chromatin analysis.
Kleppe A, Danielsen HE. Kleppe A, et al. Oncotarget. 2018 Aug 21;9(65):32406-32407. doi: 10.18632/oncotarget.25991. eCollection 2018 Aug 21. Oncotarget. 2018. PMID: 30197751 Free PMC article. No abstract available.
Designing deep learning studies in cancer diagnostics.
Kleppe A, Skrede OJ, De Raedt S, Liestøl K, Kerr DJ, Danielsen HE. Kleppe A, et al. Nat Rev Cancer. 2021 Mar;21(3):199-211. doi: 10.1038/s41568-020-00327-9. Epub 2021 Jan 29. Nat Rev Cancer. 2021. PMID: 33514930 Review.
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
Kleppe A, Skrede OJ, De Raedt S, Hveem TS, Askautrud HA, Jacobsen JE, Church DN, Nesbakken A, Shepherd NA, Novelli M, Kerr R, Liestøl K, Kerr DJ, Danielsen HE. Kleppe A, et al. Lancet Oncol. 2022 Sep;23(9):1221-1232. doi: 10.1016/S1470-2045(22)00391-6. Epub 2022 Aug 11. Lancet Oncol. 2022. PMID: 35964620
Chromatin organisation and cancer prognosis: a pan-cancer study.
Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE. Kleppe A, et al. Lancet Oncol. 2018 Mar;19(3):356-369. doi: 10.1016/S1470-2045(17)30899-9. Epub 2018 Feb 3. Lancet Oncol. 2018. PMID: 29402700 Free PMC article.
Chromatin changes predict recurrence after radical prostatectomy.
Hveem TS, Kleppe A, Vlatkovic L, Ersvær E, Wæhre H, Nielsen B, Kjær MA, Pradhan M, Syvertsen RA, Nesheim JA, Liestøl K, Albregtsen F, Danielsen HE. Hveem TS, et al. Among authors: kleppe a. Br J Cancer. 2016 May 24;114(11):1243-50. doi: 10.1038/bjc.2016.96. Epub 2016 Apr 28. Br J Cancer. 2016. PMID: 27124335 Free PMC article.
PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer.
Cyll K, Kleppe A, Kalsnes J, Vlatkovic L, Pradhan M, Kildal W, Tobin KAR, Reine TM, Wæhre H, Brennhovd B, Askautrud HA, Skaaheim Haug E, Hveem TS, Danielsen HE. Cyll K, et al. Among authors: kleppe a. Cancers (Basel). 2021 Aug 26;13(17):4291. doi: 10.3390/cancers13174291. Cancers (Basel). 2021. PMID: 34503100 Free PMC article.
20 results